Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Androgen replacement in aging men.

R M Francis1

  • 1Musculoskeletal Unit, Freeman Hospital, Newcastle upon Tyne, UK.

Calcified Tissue International
|December 4, 2001
PubMed
Summary
This summary is machine-generated.

Testosterone decline in aging men contributes to bone loss and osteoporosis. Testosterone replacement therapy improves bone density, particularly in hypogonadal men, but requires further safety and efficacy studies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Obesity, bone density relative to body weight and prevalent vertebral fracture at age 62 years: the Newcastle thousand families study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2019
Same author

No effect of monthly supplementation with 12000 IU, 24000 IU or 48000 IU vitamin D3 for one year on muscle function: The vitamin D in older people study.

The Journal of steroid biochemistry and molecular biology·2018
Same author

Does regional loss of bone density explain low trauma distal forearm fractures in men (the Mr F study)?

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2017
Same author

pophelper: an R package and web app to analyse and visualize population structure.

Molecular ecology resources·2016
Same author

Serum 25-hydroxyvitamin D concentration and its determinants in the very old: the Newcastle 85+ Study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2015
Same author

FRAX-based assessment and intervention thresholds--an exploration of thresholds in women aged 50 years and older in the UK.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2015
Same journal

Associations between controlling nutritional status and mortality in osteoporosis: evidence from NHANES, 2005-2018.

Calcified tissue international·2026
Same journal

Gut Microbiota-Derived TMAO Drives MC3T3-E1 Senescence and Osteogenic Dysfunction via cGAS-STING-NF-κB Signaling: Implications for Age-Related Bone Loss.

Calcified tissue international·2026
Same journal

Artificial Intelligence Approaches for Osteoporotic Fracture Risk Prediction Using Administrative Health Data: A Systematic Review.

Calcified tissue international·2026
Same journal

The Important Role of Polycystin in the Skeletal System.

Calcified tissue international·2026
Same journal

Effects of High-Impact Exercise on Bone Marker Concentrations During Controlled Low Energy Availability in Recreational Female Runners.

Calcified tissue international·2026
Same journal

BMAL1 Proteostasis, Circadian Dysfunction, and Ferroptotic Vulnerability in Osteoporosis: Current Evidence and Experimental Priorities.

Calcified tissue international·2026
See all related articles

Area of Science:

  • Endocrinology
  • Gerontology
  • Bone Metabolism

Background:

  • Serum testosterone and estradiol levels decrease with age in men.
  • The role of these hormonal changes in age-related bone loss is not fully understood.
  • Hypogonadism is a significant factor in male osteoporosis, affecting a substantial percentage of men with fractures.

Purpose of the Study:

  • To investigate the relationship between age-related hormonal changes and bone loss in men.
  • To evaluate the effects of testosterone replacement therapy (TRT) on bone density and resorption in hypogonadal and eugonadal men.
  • To assess potential adverse effects of TRT on prostate health and cardiovascular risk factors.

Main Methods:

  • Review of existing studies on age-related hormonal changes and bone density in men.

Related Experiment Videos

  • Analysis of data on bone loss in hypogonadal men and its proposed mechanisms.
  • Examination of the impact of testosterone replacement on bone resorption and mineralization.
  • Observation of bone density changes in response to TRT in hypogonadal and eugonadal men.

    • Main Results:

    • Testosterone replacement therapy corrects abnormalities associated with bone loss in hypogonadal men.
    • Long-term TRT can increase spine bone density by over 25%, with significant improvements in the initial years.
    • The increase in bone density with TRT is inversely related to baseline testosterone levels.
    • Even in eugonadal men with fractures, TRT showed a 5% increase in spine bone density, likely mediated by increased estradiol and reduced bone resorption.

    Conclusions:

    • Testosterone replacement therapy demonstrates beneficial effects on bone health in aging men, particularly those with hypogonadism.
    • Further research is necessary to confirm the long-term safety and efficacy of TRT for osteoporosis in both hypogonadal and eugonadal men, considering potential risks.
    • The interplay between testosterone, estradiol, and bone metabolism warrants continued investigation.